Keith T. Flaherty Insider Trading
Get free email notifications about insider trading for Keith T. Flaherty.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith T. Flaherty. Keith T. Flaherty is a Director in Clovis Oncology, Inc. ($CLVS) and a Director in Loxo Oncology, Inc. ($LOXO) and a Director in Checkmate Pharmaceuticals, Inc. ($CMPI).
Address: C/O CLOVIS ONCOLOGY, INC. 2525 28TH STREET, SUITE 100 BOULDER 80301 CO
Companies in which Keith T. Flaherty is an Insider
Checkmate Pharmaceuticals, Inc.
Trading Symbol: CMPIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Keith T. Flaherty: Director
Holdings: 0 shares
Latest Transaction: Jun 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith T. Flaherty: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 05 2020
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Loxo Oncology, Inc.
Trading Symbol: LOXOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith T. Flaherty: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 15 2019
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Keith T. Flaherty
Sentiment: All, CMPI, CLVS, LOXO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | CMPI | Checkmate Pharmace ... | Flaherty Keith T. | Director | Option Exercise | A | 6.27 | 10,030 | 62,888 | 10,030 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | Flaherty Keith T. | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | Flaherty Keith T. | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | Flaherty Keith T. | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Flaherty Keith T. | Director | Option Exercise | D | 180.98 | 8,750 | 1,583,575 | 0 | |
Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Flaherty Keith T. | Director | Option Exercise | D | 84.88 | 2,500 | 212,200 | 0 | |
Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Flaherty Keith T. | Director | Option Exercise | D | 78.58 | 11,000 | 864,380 | 0 |